Article Details

Rising Star: Vega Targets Rare Blood Disorders with Antibodies

Retrieved on: 2022-12-27 19:46:15

Tags for this article:

Click the tags to see associated articles and topics

Rising Star: Vega Targets Rare Blood Disorders with Antibodies. View article details on hiswai:

Excerpt

During the first nine months of 2022, Hemlibra was Roche's third highest-selling treatment, generating CHF 2.778 billion ($2.977 billion), up 28% from ...

Article found on: www.genengnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up